From the archives 🎙️ On this episode of the Heart Failure Beat, hosts @MHBeasleyMD and @priyaumapathi, MD, sit down with Amanda Vest, MBBS, MPH, FHFSA, and Adrian daSilva-deAbreu, MD, PhD(c), MSc, D.A.B.O.M., to discuss the evaluation and management of obesity in patients with heart failure. Obesity is one of the most common comorbidities heart failure cardiologists encounter, and this conversation makes the case for why it belongs squarely in our lane. 🔗 Listen now: hfsa.org/heart-failure-beat-…

HFSA Members get full access to HF Stats: downloadable charts, infographics, and expert-driven HF data ready for your next presentation, grant, or research project. 📊 Get full access before the new report drops October 5th! 🔗 Explore HF Stats: hfstats.org?utm_source=x&utm…

The perfect onboarding resource for your heart failure care team. ✅ "Knowing this was HFSA's educational format, we felt confident that the APPs were getting current and accurate information," says Jennifer Thibodeau, MD, UT Southwestern Medical Center. 🔗 Learn more: hfsa.org/professional-develo…

Learn more about this year's Lifetime Achievement Award recipient, Gregg C. Fonarow, MD, FHFSA. 🏆 Dr. Fonarow shares career highlights, his outlook on the future of heart failure care, and advice for those entering the field. Don't miss his award ceremony onsite at #HFSA2026 on Saturday, October 10. 🔗 Read the full spotlight: hfsa.org/lifetime-achievemen…

How should we assess congestive hepatopathy in advanced HF? Conventional liver tests can be misleading. This State-of-the-Art review explores multimodality assessment, including biopsy & HVPG, and individualized heart vs heart-liver transplant decisions. bit.ly/4h0LNPK

A first look at U.S. heart failure clinic infrastructure: 306 programs, 47 states, 98 clinical and operational variables - the largest dataset of its kind. Read the inaugural HFSA report: hfsa.org/hfsa-heart-failure-…

🏃‍♀️🏃‍♂️ #CardioNerds5K is coming to #HFSA2026! 📍 Phoenix, AZ 📅 Sunday, October 11, 7 am Run it. Walk it. Nerd out. ❤️🤓 Start your Sunday with friends, colleagues & the #CardioNerds community—and get your heart pumping before another great day at HFSA! 🔗 Register here: youkeepmoving.com/race/cardi…

Just a reminder that the #Cardionerds5K is coming to #HFSA2026 @HFSA It's free, it's fun, it's a great way to practice what we preach!! There'll be post-race food/drinks in the exhibit hall following the race. Register here: youkeepmoving.com/race/cardi…

Download the HFSA ASM 2026 App Today! Explore scientific sessions and speakers as you build your own agenda for the meeting; watch sessions OnDemand approximately 24 hours after they appear in-person; browse ePosters and learn about intriguing new research; connect with other attendees; explore exhibitors, and more! Download now: hfsa.org/asm/mobile-app

Head west this October. 🌵 The heart failure community is gathering in Phoenix for #HFSA2026, four days of science, collaboration, and connection. Don't miss it!! 📍 Phoenix Convention Center | 🗓 October 9–12, 2026 🔗 Secure your spot: hfsa.org/asm/registration?ut…

Can we improve not just survival rates, but health status for patients with TTR amyloid cardiomyopathy? CARDIO-TTRansform, presenting at #HFSA2026, puts eplontersen to the test. Join us for late-breaking results Oct 9-12, Phoenix bit.ly/46zd9Yz

These aren't sessions you'll find at any other HF meeting. The HFSA Devices Meeting 2026 brings interactive, high-energy formats together with real clinical debate, covering everything from building a device clinic to working with the FDA to change heart failure care. 📅 October 9 | Phoenix, AZ | Immediately before #HFSA2026 Attend both the Devices Meeting and ASM and save $100 automatically at checkout! 🔗 Register now: hfsa.org/asm/hfsa-devices-me…

Could there be a new pillar of treatment for heart failure? At #HFSA2026, late-breaking data from Cycle-1 REF and Cycle-2 PEF will explore tovinontrine's impact on patients with HFrEF and HFpEF. Join us Oct 9-12 in Phoenix to see the data bit.ly/46zd9Yz

Can clinician education help translate HF guidelines into clinical practice? 📖 New Cleveland Clinic research in @JCardFail found that completion of HFSA's OMT-HF program was associated with an increase in new SGLT2i prescribing among non-cardiologist clinicians. 📖 Read the study: onlinejcf.com/article/S1071-… 🔗 Enroll for $175: hfsa.org/optimal-medical-the…

Why attend the HFSA Devices Meeting 2026? 🔬 Focused, device-specific education 🏥 Real-world application you can use immediately 🤝 Direct engagement with experts and industry Attend both the Devices Meeting and ASM and save $100 automatically! 🔗 Register now: hfsa.org/asm/hfsa-devices-me…

In-person recruitment for heart failure research yielded a 41% consent rate, 20x higher than EHR messaging, and closed a racial enrollment gap that persisted with phone and EHR outreach 📊 New in @JCFIntersections, plus research on cardiac ICU sedation, HF in pregnancy, and congestive hepatopathy. 🔗 View the full issue: onlinejcfi.org/current

Bridging the gap in heart failure genetics. 🧬 A practical, case-based webinar to help cardiologists, nurses, NPs, PAs, and genetic counselors confidently navigate genetic results, including VUS management and precision medicine. 🗓 Sept. 23 | 🕒 3:00 PM ET | Free 🔗 Register now: hfsa.org/event/navigating-un…

Happening today 💙 HFSA's webinar, A Woman's Heart: Understanding ATTR-CM, covers how ATTR-CM presents in women and how to advocate for earlier detection. 🗓 September 15 | 6:00–6:45 PM ET | Free Share with patients who could benefit. 🔗 Register now: hfsa.org/womans-heart-unders…

⏰ FINAL HOURS Submissions for the @JCardFail Focus Issue: The New Frontier of Heart Function in Women close September 15. Don't miss it. 🔗 Submit now: hfsa.org/journal-cardiac-fai…

New CardioBites: Recognizing the Clues 🔍 Identifying the signs and symptoms of systemic light chain amyloidosis is crucial for improving diagnostic accuracy. This short video explores the clues that are often missed. 🔗 Watch now: piped.video/gzEzvfL657M